SARA COLLESIDES: Open Payments
NPI 1528767084 · COXSACKIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 29 payments from 11 companies in 2025. Trend: 2023 $226 · 2024 $531 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $124 |
| PFIZER INC. | 6 | $110 |
| Exact Sciences Corporation | 3 | $82 |
| Novo Nordisk Inc | 3 | $58 |
| Abbott Laboratories | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $16 |
Products named: TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, PREVNAR 20, ELIQUIS, FREESTYLE LIBRE 3, Auvelity, Kerendia, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
